ABBV vs JNJ
ABBV and JNJ side by side — valuation & fundamentals (public data).
Key statistics
| Metric | ABBVAbbVie Inc. | JNJJohnson & Johnson |
|---|---|---|
| Market cap | $454.39B | $640.29B |
| P/E (TTM) | 72.6 | 30.8 |
| P/B | — | 7.54 |
| P/S | 7.4x | 6.8x |
| Dividend yield | 2.57% | 1.93% |
| Revenue | $61.16B(TTM) | $97.93B(TTM) |
| Revenue growth (YoY) | 8.6% | 6.0% |
| Net income | $6.31B(TTM) | $21.04B(TTM) |
| Earnings growth (YoY) | -1.2% | 90.6% |
| EPS, diluted | $3.54(TTM) | $8.62(TTM) |
| EBIT margin | 24.6% | 22.9% |
| ROE | — | 31.5% |
| ROIC | 18.6% | 16.1% |
| Piotroski F | — | 6/9 |
| 1y total return | +19.8% | +51.7% |
Figures from SEC filings · for reference only · not investment advice
$10,000 투자 성장: ABBV vs JNJ
| 지표 | ABBV | JNJ |
|---|---|---|
| 최종 가치 | $61.4K | $30.8K |
| 총수익률 | +513.5% | +208.2% |
| CAGR | +19.2% | +11.5% |
| 변동성 | 25.9% | 18.6% |
| 샤프 | 0.65 | 0.46 |
| 소르티노 | 0.91 | 0.65 |
| 최대 낙폭 | -45.1% | -27.4% |
공통 거래일 2600일 기준, 2016-05-10 → 2026-09-11 · 무위험수익률 4.07% (현재 단기 국채 금리, 고정 적용)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)